<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06760000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q13619</UniProt_ID>
  <Seq_Length>759</Seq_Length>
  <Molecule_Weight>87680</Molecule_Weight>
  <KEGG_ID>hsa:8451</KEGG_ID>
  <Orthology_ID>K10609</Orthology_ID>
  <EBI_ID>EBI-456106</EBI_ID>
  <Function_Summary>Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the deneddylated cullin subunit with TIP120A/CAND1. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition component. DCX(DET1-COP1) directs ubiquitination of JUN. DCX(DDB2) directs ubiquitination of XPC. In association with RBX1, DDB1 and DDB2 is required for histone H3 and histone H4 ubiquitination in response to ultraviolet and may be important for subsequent DNA repair. DCX(DTL) plays a role in PCNA-dependent polyubiquitination of CDT1 and MDM2-dependent ubiquitination of TP53 in response to radiation-induced DNA damage and during DNA replication. In association with DDB1 and SKP2 probably is involved in ubiquitination of CDKN1B/p27kip. Is involved in ubiquitination of HOXA9.</Function_Summary>
  <Pfam_ID>PF00888:Cullin@@PF10557:Cullin_Nedd8</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CUL-4A</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.</Detail>
      <Keyword>Ubiquitin protein ligase binding</Keyword>
      <Ontology_ID>GO:0031625</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>644</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process induced by intracellular signals that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis by intracellular signals</Keyword>
      <Ontology_ID>GO:0008629</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.</Detail>
      <Keyword>Ubiquitin-dependent protein catabolic process</Keyword>
      <Ontology_ID>GO:0006511</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Progression from G1 phase to S phase of the mitotic cell cycle.</Detail>
      <Keyword>G1/S transition of mitotic cell cycle</Keyword>
      <Ontology_ID>GO:0000082</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.</Detail>
      <Keyword>Response to DNA damage stimulus</Keyword>
      <Ontology_ID>GO:0006974</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in ubiquitin-like modifier processing, activation, conjugation or deconjugation such as Ubl-activating enzymes (E1s), Ubl-conjugating enzymes (E2s), Ubl-protein ligases (E3s), some thiol proteases (Ubiquitin carboxyl-terminal hydrolases (UCH), Ubiquitin-specific processing proteases (UBP) and ubiquitin-like proteases) and the ubiquitin-like modifier proteins. Besides signaling proteolysis, ubiquitination for example can be a signal for trafficking, kinase activation and other nonproteolytic fates.</Detail>
      <Keyword>Ubl conjugation pathway</Keyword>
      <Ontology_ID>KW-0833</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of cell proliferation.</Detail>
      <Keyword>Negative regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008285</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).</Detail>
      <Keyword>Cell cycle arrest</Keyword>
      <Ontology_ID>GO:0007050</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.</Detail>
      <Keyword>DNA repair</Keyword>
      <Ontology_ID>GO:0006281</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>10</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>227</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>22</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>99</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MADEAPRKGSFSALVGRTNGLTKPAALAAAPAKPGGAGGSKKLVIKNFRDRPRLPDNYTQDTWRKLHEAVRAVQSSTSIRYNLEELYQAVENLCSHKVSPMLYKQLRQACEDHVQAQILPFREDSLDSVLFLKKINTCWQDHCRQMIMIRSIFLFLDRTYVLQNSTLPSIWDMGLELFRTHIISDKMVQSKTIDGILLLIERERSGEAVDRSLLRSLLGMLSDLQVYKDSFELKFLEETNCLYAAEGQRLMQEREVPEYLNHVSKRLEEEGDRVITYLDHSTQKPLIACVEKQLLGEHLTAILQKGLDHLLDENRVPDLAQMYQLFSRVRGGQQALLQHWSEYIKTFGTAIVINPEKDKDMVQDLLDFKDKVDHVIEVCFQKNERFVNLMKESFETFINKRPNKPAELIAKHVDSKLRAGNKEATDEELERTLDKIMILFRFIHGKDVFEAFYKKDLAKRLLVGKSASVDAEKSMLSKLKHECGAAFTSKLEGMFKDMELSKDIMVHFKQHMQNQSDSGPIDLTVNILTMGYWPTYTPMEVHLTPEMIKLQEVFKAFYLGKHSGRKLQWQTTLGHAVLKAEFKEGKKEFQVSLFQTLVLLMFNEGDGFSFEEIKMATGIEDSELRRTLQSLACGKARVLIKSPKGKEVEDGDKFIFNGEFKHKLFRIKINQIQMKETVEEQVSTTERVFQDRQYQIDAAIVRIMKMRKTLGHNLLVSELYNQLKFPVKPGDLKKRIESLIDRDYMERDKDNPNQYHYVA</Protein_Seq>
    <DNA_Seq>CCGGCCCAGCCATGGCGGACGAGGCCCCGCGGAAGGGCAGCTTCTCGGCGCTCGTGGGCCGCACCAACGGCCTCACCAAGCCCGCGGCCCTGGCCGCCGCGCCCGCCAAGCCGGGGGGCGCGGGCGGCTCCAAGAAGCTGGTCATCAAGAACTTCCGAGACAGACCTCGGCTGCCCGACAACTACACGCAGGACACGTGGCGGAAGCTGCACGAGGCGGTGCGGGCCGTGCAGAGCAGCACCTCCATCAGGTACAACCTCGAGGAGCTCTACCAGGCTGTGGAAAATCTCTGTTCTCACAAAGTCTCCCCAATGCTCTACAAGCAACTGCGTCAGGCCTGTGAAGACCACGTCCAGGCACAGATCCTTCCGTTTAGAGAAGACTCACTAGATAGTGTTTTATTTTTAAAGAAGATTAACACGTGCTGGCAGGACCACTGCAGACAAATGATCATGATCAGAAGCATCTTCCTGTTCTTGGACCGCACCTATGTGCTGCAGAACTCCACGCTGCCCTCCATCTGGGATATGGGATTAGAACTGTTTAGAACCCATATTATTAGTGATAAAATGGTTCAGAGTAAAACCATTGATGGAATCCTACTGCTGATCGAGCGCGAGAGGAGCGGCGAGGCCGTGGACCGGAGCCTGTTGCGGAGCCTCCTGGGCATGCTGTCTGACCTGCAGGTGTATAAAGATTCATTTGAACTGAAATTTTTGGAAGAGACTAATTGCTTATATGCTGCCGAAGGCCAAAGGTTAATGCAGGAAAGAGAGGTTCCAGAATATCTTAACCATGTAAGTAAACGCTTAGAGGAAGAGGGAGACAGAGTAATCACTTACTTGGACCACAGCACACAGAAACCACTGATTGCTTGTGTGGAGAAACAGCTATTAGGAGAACATTTAACAGCAATTCTGCAGAAAGGGCTCGACCACTTACTGGATGAGAACAGAGTGCCGGACCTCGCACAGATGTACCAGCTGTTCAGCCGGGTGAGGGGCGGGCAGCAGGCGCTGCTGCAGCACTGGAGCGAGTACATCAAGACTTTTGGAACAGCGATCGTAATCAATCCTGAGAAAGACAAAGACATGGTCCAAGACCTGTTGGACTTCAAGGACAAGGTGGACCACGTGATCGAGGTCTGCTTCCAGAAGAATGAGCGGTTCGTCAACCTGATGAAGGAGTCCTTTGAGACGTTCATCAACAAGAGACCCAACAAGCCTGCAGAACTGATCGCAAAGCATGTGGATTCAAAGTTAAGAGCAGGCAACAAAGAAGCCACAGACGAGGAGCTGGAGCGGACGTTGGACAAGATCATGATCCTGTTCAGGTTTATCCACGGTAAAGATGTCTTTGAAGCATTTTATAAAAAAGATTTGGCAAAAAGACTCCTTGTTGGGAAAAGTGCCTCAGTCGATGCTGAAAAGTCTATGTTGTCAAAGCTCAAGCATGAGTGCGGTGCAGCCTTCACCAGCAAGCTGGAAGGCATGTTCAAGGACATGGAGCTTTCGAAGGACATCATGGTTCATTTCAAGCAGCATATGCAGAATCAGAGTGACTCAGGCCCTATAGACCTCACAGTGAACATACTCACAATGGGCTACTGGCCAACATACACGCCCATGGAAGTGCACTTAACCCCAGAAATGATTAAACTTCAGGAAGTATTTAAGGCATTTTATCTTGGAAAGCACAGTGGTCGAAAACTTCAGTGGCAAACTACTTTGGGACATGCTGTTTTAAAAGCGGAGTTTAAAGAAGGGAAGAAGGAATTCCAGGTGTCCCTCTTCCAGACACTGGTGCTCCTCATGTTCAACGAGGGAGATGGCTTCAGCTTTGAGGAGATAAAAATGGCCACGGGGATAGAGGATAGTGAATTGCGCAGAACGCTGCAGTCCCTGGCCTGTGGCAAAGCACGTGTGCTGATTAAAAGTCCCAAAGGAAAGGAAGTGGAAGATGGAGACAAGTTCATTTTTAATGGAGAGTTCAAGCACAAGTTGTTTAGAATAAAGATCAATCAAATTCAGATGAAGGAAACTGTTGAGGAACAGGTTAGCACCACTGAGAGAGTGTTTCAGGATAGACAATATCAGATTGATGCTGCTATCGTCAGAATAATGAAGATGAGAAAGACTCTTGGTCATAATCTTCTAGTTTCTGAATTATATAATCAGCTGAAATTTCCAGTAAAGCCTGGAGATTTGAAAAAGAGAATTGAATCTCTGATAGACAGAGACTATATGGAGAGAGACAAAGACAATCCGAATCAGTACCACTACGTGGCCTGACGCATCTGCAGACGGTTCCCCTTCATGAAACACTAGAATGTACCCTCAGAGCAGGAAGCACACCTGTGCCATTTCTGGGACTCTGATTGATCCAGCTGTGGACATTGGAAGGCGAAGGAAGGGAGGTGGCTCCTGGGTCATCTTTCACAAGGCTCAAGACTTCAACCTGCAGATGTATCTTTTTCCCTCCAGTTTTTCCTCTAGTTCTTTTAGGCATTTAAATTGTTTCTGTTACTCTGTGCAAAATAACTTTGAGATTGGACAAGAAGATGTTACTAAAGAGAAGTTCCTTTAAAAGGTCTTGTTCTTGTGTCAAAAAGCTGCAAGTTTGGTTTGTTCTCGTGTGTGATCATGAGTGCACAATGAAGAAGACCCTAGATGCTGCATTTTTTAGCTCTGAAGATTCCTTAGGTATCCCTGAAGACAGCTCGCTCAGATGATCAGCATTTAGAGTGAAAACAAGGGCCCTTCATGGGTGAACATTAGAAAGAGCCAGGGTTCAAAGCTGGCGAATGGATGACGCACCCTAGCCACTGGCCCCTCTCTGTTTCATGTATTTCCAAAAGTTGTAAACTTTGATGGCTGATTTTTCGTAAGTCAGGTTTCTAAGTGAGCTCCCTGAGGTGCCAAGGCCATGGTGTCCGCCCTGCTGCGTCTGTTCGTCAGCTGAGTTCCTTGTGAATCTCTGTTTTAGGGTTTGGGGCTAGTGTGTTTGTGTTTCCATTCTAAGATTGAGTCTGGCAGTCCCTGTTTTTTTGCATTGGGGTAACTGCTCTTTGATTTTTTTTAATTGCAGTATTTGTGTGATTGCAATAATAAAGTTTGGTTTGGTTTTTACAGTCATGCGCAGGGACGATCCTTGTTCTCTGCTGTAAACTGTAAAAAGTTTATGGAGACTTAAAGTCTTGATGTTGTGAAGCAGAGGTTATTTTGTGGAAAGATTAAAAGGATTTTGTTGGTACCTGGTTTTGTGTTGTGTATATATACATGAGGTTGAACAGTGAAAGGAAAGTTCAGTAGTGATGTTAGAAGGGTAACTATGACAAAGATACTTTTGAGATAACATTTAAAAGTACTTTATATTTTACATAATAGCATGTTTCATTTTGATTAAAAGCTACCAAAGGAATTTTGATCATGGCATAAGTGTTTAAAGCAATATTTTCTGGAATATACCAAGTTTATATAATTTGATTTTGTGCTAAATTATTAAGAGTCTCTTTTTGAAACATGCGGGTTTGAAATATGACACCTTGTGGGTTTCCATATTAAAATCCTCACTCTTTAATTGTCATTTCTATCTTTGAAAATTTTCATTTATGAGTTCCATGATATGTGGTCTAAGAAAGACCAAACAGATTTCTATTTTTTTTTTCTTATAAGTTCGTTGTGTCTAGAGATTGTTAATATTGTAATTTAATGTAGACTTACTTTGAATAAAATTAGTTTAATTGGCCTTAAAATTACATTAATAAAACTTTGTGATATGCAAATGAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cul4A-RING ubiquitin ligase complex</CellLocal>
      <Ontology_ID>GO:0031464</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CUL4A</Gene_Name>
    <Gene_ID>8451</Gene_ID>
    <Genbank_ACCN>NM_001008895</Genbank_ACCN>
    <Protein_ACCN>NP_001008895</Protein_ACCN>
    <HGNC_ID>2554</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/8451</Gene_URL>
    <UCSC_ID>uc010agu.3</UCSC_ID>
    <EMBL_ID>ENSG00000139842</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q15291</Uniprot_ID>
      <Gene_Name>RBBP5</Gene_Name>
      <EBI_ID>EBI-592823</EBI_ID>
      <PPI_EBI_URL>EBI-456106,EBI-592823</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q86VP6</Uniprot_ID>
      <Gene_Name>CAND1</Gene_Name>
      <EBI_ID>EBI-456077</EBI_ID>
      <PPI_EBI_URL>EBI-456106,EBI-456077</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q92466</Uniprot_ID>
      <Gene_Name>DDB2</Gene_Name>
      <EBI_ID>EBI-1176171</EBI_ID>
      <PPI_EBI_URL>EBI-456106,EBI-1176171</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Glomuvenous Malformation</Disease_Name>
      <Disease_Detail>Glomuvenous Malformation</Disease_Detail>
      <Disease_DB>GLM034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glomuvenous_malformation?search=CUL4A#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>STRUCTURE OF DDB1-DDB2-CUL4A-RBX1 BOUND TO A 12 BP ABASIC SITE CONTAINING DNA-DUPLEX</PDB_Title>
      <PDB_ID>4A0K</PDB_ID>
      <Resolution>5.93</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4A0K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Molecular Basis of Crl4(Ddb2/Csa) Ubiquitin Ligase Architecture, Targeting, and Activation.</PubMed_Title>
      <Author>Fischer, E.S., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2011)147:1024</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22118460?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the DDB1-Cul4A-Rbx1-SV5V Complex</PDB_Title>
      <PDB_ID>2HYE</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HYE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.</PubMed_Title>
      <Author>Angers, S., et al.</Author>
      <Journal>Nature(2006)443:590-593</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16964240?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>Multi-domain proteins (alpha and beta)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.f.dg.b.b.c.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/2hye</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Hinge</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>